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Abstract: Background: Polycarprolactone and beta tricalcium phosphate (PCL/β-TCP) are resorbable
biomaterials that exhibit ideal mechanical properties as well as high affinity for osteogenic cells.
Aim: Objective of this study was to evaluate healing and tissue reaction to the PCL/β-TCP barrier
membrane in the rabbit calvaria model for guided bone regeneration. Materials and Methods:
The PCL/β-TCP membranes were 3D printed. Three circular defects were created in calvaria of
10 rabbits. The three groups were randomly allocated for each specimen: (i) sham control; (ii) PCL/β-
TCP membrane (PCL group); and (iii) PCL/β-TCP membrane with synthetic bone graft (PCL-BG
group). The animals were euthanized after two (n = 5) and eight weeks (n = 5) for volumetric and
histomorphometric analyses. Results: The greatest augmented volume was achieved by the PCL-BG
group at both two and eight weeks (p < 0.01). There was a significant increase in new bone after
eight weeks in the PCL group (p = 0.04). The PCL/β-TCP membrane remained intact after eight
weeks with slight degradation, and showed good tissue integration. Conclusions: PCL/β-TCP
membrane exhibited good biocompatibility, slow degradation, and ability to maintain space over
eight weeks. The 3D-printed PCL/β-TCP membrane is a promising biomaterial that could be utilized
for reconstruction of critical sized defects.
Keywords: polycarprolactone; beta tricalcium phosphate; guided bone regeneration; membrane;
3D printing
1. Introduction
Guided bone regeneration (GBR) is a procedure in which a barrier membrane is placed
to create a secluded space for the growth of newly mineralized tissue [1]. This procedure
is performed in the alveolar crest of patients needing dental implant placement as the
supporting bone structures frequently undergo extensive resorption after tooth extraction.
The barrier membrane is a critical component of the (GBR) procedure as it separates the
defect space from the overlying soft tissues and provides stability for regeneration to
occur [1,2]. Until now, numerous non-resorbable and resorbable membranes have been
applied with varying degrees of success, and among them, the combination of bone graft
particles and collagen membrane is the most commonly used [3]. The collagen membrane
is a popular choice as it exhibits excellent biocompatibility and tissue integration. In
addition, the collagen is biodegradable; therefore, no additional surgery is needed for
membrane removal. However, the collagen membrane lacks some important characteristics
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such as space maintenance, structural stability, and longevity; which are necessary for the
regeneration of severe uncontained defects [4].
For the reconstruction of large defects of the jaw, various options have been consid-
ered. Use of numerous fixation pins in combination with collagen membrane and bone
graft particles has been suggested previously [5]. Block bone grafts from various sources
including autogenous, allogenic, and xenogenic have been utilized [6,7]. Various scaf-
fold materials for bone tissue engineering have been studied as carriers for osteogenic
stem cells or growth factors [8,9]. Non-resorbable barrier membranes made of e-PTFE
(expanded-polytetrafluoroethylene), d-PTFE (dense-PTFE), and titanium mesh have all
been tried due to their superior structural stability and space maintenance [10,11]. How-
ever, all of these have drawbacks and complications such as frequent membrane exposure,
wound dehiscence, and resulting morbidity of the recipient site [12]. Therefore, there is
a tremendous need for a new membrane in this clinical situation that exhibits not only
biodegradability, biocompatibility, and tissue integration like the collagen membrane, but
also good structural stability and longevity as the non-resorbable membranes.
A synthetic bioresorbable membrane using a combination of polycarprolactone (PCL)
and beta tricalcium phosphate (β-TCP) has recently been introduced to overcome the
drawbacks of existing membranes [13]. The PCL/β-TCP membrane showed increased me-
chanical stability and slower degradation compared to conventional collagen membranes
with reliable bone regeneration [14]. Simultaneously, the PCL/β-TCP membrane degrades
to allow infiltration of cell growth, which induces adequate blending and biocompatible
degradation to prevent membrane exposure [15].
Since the PCL/β-TCP membrane is fabricated with 3D printing techniques, the mem-
brane can be designed and printed as an individually tailored membrane, which fits to each
bone defect [13]. Acquiring a perfect fit around a bone defect can result in reduced surgery
time as well as the prevention of membrane exposure [16]. Thus, due to complementary
characteristic of PCL/β-TCP, the 3D printed PCL/β-TCP membrane can simultaneously
show similar longevity and mechanical stability of non-resorbable membrane and no
necessity of additional surgery [17].
Previous studies have shown the efficacy of PCL/β-TCP membrane in vitro and
in vivo [13,14]. However, there was a lack of histologic evaluation in the early healing
stage and thorough observation regarding tissue reaction to the PCL/β-TCP membrane
per se. Thus, the objective of this study was to evaluate healing and tissue reaction to the
PCL/β-TCP membrane in the rabbit calvaria model.
2. Materials and Methods
2.1. Animals
Ten New Zealand male white rabbits (3~3.5 kg) were prepared for the study. All
surgical procedures and animal management were according to the Association for Assess-
ment and Accreditation of Laboratory Animal Care International (AAALAC) guidelines
and approved by the Animal Institution Animal Care and Use Committee of Yonsei Medi-
cal Center.
2.2. Preparation of the PCL and β-TCP Mixture
A PCL/β-TCP membrane (LT6 membrane, Megagen, Daegu, Korea) was used in
the study. A detailed manufacturing process has been described in a previous study [18].
In brief, PCL (19561-500G, Polysciences Inc., Warrington, PA, USA) and β-TCP (average
diameter: 100 nm, Berkeley Advanced Biomaterials Inc., Berkeley, CA, USA) were blended
by a melting process. Inside a glass container, PCL chips were melted to a thermally molten
state at 120 ◦C for 15 min. β-TCP powder was added to the molten PCL and blended
together (7:3 ratio of PCL:β-TCP by weight). The molten mixture of PCL and β-TCP were
blended for 10 min.
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2.3. Fabrication of the PCL/β-TCP Membrane Using a 3D Printer
A micro-extrusion based 3D printer was developed for the fabrication of the PCL/β-
TCP membrane, which has been described in detail in a previous study [18]. In brief, the
PCL/β-TCP in a molten state (120 ◦C) was loaded on the multi-head deposition system
(MHDS) of the 3D printer. Six-dispensing heads were mounted in the system, which
were individually controllable. Four of the heads were connected to a heating system that
could melt thermoplastic biomaterials. Melts were dispensed from the nozzle of the 3D
printer at 110 ◦C and 500 kPa. A dispenser that regulates pneumatic pressure was used
to extrude the molten biomaterial. The extruded PCL/β-TCP was rapidly cooled and
hardened at room temperature. By layer-by-layer, 3D mesh type structure with four layers
was printed. Finally, membranes of 30 mm × 20 mm × 0.15 mm size with 250 µm of pore
size were produced.
2.4. Synthetic Bone Graft Material
Synthetic bone graft material (Bone Matrix I, Megagen, Daegu, Korea) was used in the
study. The synthetic bone graft was biphasic calcium phosphate (BCP), which consisted of
hydroxyapatite (HA): β-TCP on 60:40 in weight. Pore size of the particle was 100~500 µm
for macroporosity and 10~50 µm for microporosity.
2.5. Study Design
Ten rabbits were divided into two groups according to healing periods of two and
eight weeks, each group containing five rabbits. In the calvarium, three defects having
diameter of 8 mm were formed and allocated to the following study groups (Figure 1).
i. Sham control group;
ii. PCL/β-TCP membrane group (PCL group): the defect was covered using the
PCL/β-TCP membrane (10 mm × 10 mm) without bone graft; and
iii. PCL/β-TCP membrane with synthetic bone graft group (PCL-BG group): the defect
was filled with synthetic bone graft material and covered using the PCL/β-TCP
membrane.
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Figure 1. Photograph of the surgical procedure. (A) Three round defects with 8-mm diameter were
prepared in the calvaria using a trephine bur. (B) Each defect was randomly allocated to a study
group. Clockwise from bottom left; PCl-BG, control, and PCL.
2.6. Surgical Procedure
Surgical procedures were described in detail in a previous publication [19]. In brief,
surgeries were performed under general anesthesia using inhalation of 2.5% isoflurane and
intravenous injection of alfaxan (5 mg/kg). Before incision, surgical sites were disinfected
with povidone iodine, and infiltration anesthesia was carried out using 2% lidocaine with
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1:80,000 adrenaline. The incision was made along the midline of the calvarium from the
frontal bone to the occipital bone, and a full-thickness flap was raised. Three circular
defects were made with a trephine bur of 8 mm inner-diameter and each defect was treated
as allocated by the study design. Flaps were repositioned and sutured with resorbable
suture material (4-0 Vicryl, Ethicon, Somerville, NJ, USA). Sutures were removed one week




The surgical sites were observed for any signs of inflammation and adverse reaction
every day until the rabbit was sacrificed.
2.7.2. Micro-Computed Tomography (Micro-CT) Analysis
The samples were harvested and fixed in 10% formalin over 10 days. They were
scanned using a micro-computed tomography (µCT) system (Sky-Scan 1173, SkyScan,
Aartselaar, Belgium). The imaging resolution was 13.85 µm (130 kV, 60 µA). The files
were processed in DICOM (Digital Imaging and Communications in Medicine) format and
reconstructed using On-Demand 3-dimensional (3D) software (Cybermed, Seoul, Korea).
For volumetric analysis of the grafted region, the ROImc (region of interest micro-CT)
was defined as: the defect margins, laterally; dura mater, inferiorly; and connective tissue
border, superiorly. Within the ROImc, the analyzed parameters were:
• Total augmented volume (TAV): the volume of the entire grafted materials and regen-
erated tissue.
• New bone volume (NBV): the volume of newly formed bone.
For the volumetric analyses of the above parameters, NRecon 1.6.9.8 software was
used (Skyscan). Specific 8-bit threshold grayscale values were used for distinguishing the
newly formed bone from residual bone substitute. For newly formed bone, the grayscale
values were set from 72 to 120 and for bone substitute from 120 to 255.
2.7.3. Histologic Analysis
Following the micro-CT scan, the fixed samples were decalcified in 5% formic acid for
10 days and then embedded in paraffin. The grafted sites were sectioned through the central
portion, and 5 µm thick sections were obtained from the middle of the defect. The selected
sections were stained with hematoxylin and eosin and Masson trichrome. Observations
of the various cells (inflammatory cells, osteoblasts, osteocytes osteoclasts), vasculature,
tissues (bone, loose connective tissue), materials (bone substitute, remaining membrane)
inside the defect were made using a light microscope (DM LB, Leica Microsystems, Wetzlar,
Germany) equipped with a camera (BX50, Olympus, Tokyo, Japan). After the examination,
computer-aided organizational measurements were performed for histomorphometric
analysis (Photoshop CS6; Adobe Systems, San Jose, CA, USA).
ROIh (region of interest, histologic) was defined by the original defect margin, laterally;
dura mater, inferiorly; the periosteum or subcutaneous tissues, superiorly. Within the ROIh,
the following parameters were measured:
• Total augmented area (TAA): the area of entire augmented tissues consisting of bone
substitute, newly formed bone, loose fibrous connective tissue, and adipose tissue.
• New bone area (NBA): the area of newly formed bone, which can be immature woven
bone or mature lamellar bone.
2.8. Statistical Analysis
Statistical analysis was performed using a commercial SPSS software program (IBM
SPSS Statistics 23; SPSS, Chicago, IL, USA). The Kruskal–Wallis test was used for com-
parisons between groups at each time point, and the Mann–Whitney U test was used to
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evaluate the measured parameters between each experimental group. Data are expressed
as mean ± standard deviation values with a statistical significance level of 5% (p < 0.05).
3. Results
3.1. Clinical Observation
No adverse reactions including bleeding and swelling were found after surgery. In
addition, the surgical sites healed well without infection or flap exposure. All animals
remained healthy throughout the experimental period.
3.2. Micro-CT Analysis
The results of the volumetric analysis are presented in Table 1. Representative view
of the micro-CT analysis is shown in Figure 2. At two and eight weeks postoperatively,
the PCL-BG group showed significantly greater TBV and NBV compared to the control
and PCL groups (p = 0.008). Between two and eight weeks, only the PCL group showed a
significant increase in NBV (p = 0.043).
Table 1. Results from the micro-CT analysis.




CONTROL 3.13 ± 2.13 2.94 ± 2.04
PCL 3.34 ± 1.88 3.22 ± 1.94
PCL-BG 28.94 ± 8.15 *,# 16.14 ± 8.38 *,#
8 weeks
CONTROL 10.89 ± 11.77 10.42 ± 11.59
PCL 20.41 ± 5.75 † 19.45 ± 5.17 †
PCL-BG 62.20 ± 21.58 *,# 33.55 ± 12.08 *,#
Values are presented as mean ± standard deviation. * Statistically significant difference compared to the control
group. # Statistically significant difference compared to the PCL group. † Statistically significant difference
between two and eight weeks.




Figure 2. Micro-computed tomographic view of each group at two and eight weeks. Bone is shown 
in purple, bone substitute particles are shown in yellow-blue. Control group at eight weeks: new 
bone formation originated from the native marginal bone. PCL group at eight weeks: bone for-
mation was visible in the middle third of the defect as the defect space was maintained by the PCL/β-
TCP membrane. 
3.3. Observational Histology (Figure 3) 
 
Figure 3. Histological view of each group at two and eight weeks. After eight weeks, the PCL/β-
TCP membrane remained intact. Minimal inflammatory reaction was observed. The PCL-BG groups 
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bar = 1 mm). 
Figure 2. Micro-computed tomographic view of each group at two and eight weeks. Bone is shown
in purple, bone substitute particles are shown in yellow-blue. Control group at eight weeks: new bone
formation originated fro the native marginal bone. PCL group at eight weeks: bon formation was
visible in the middle third of the defect as the defect space was maintained by the PCL/β-TCP membrane.
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3.3. Observational Histology
Figure 3 shows the histological view of each group at two and eight weeks.
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TCP membrane. 
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3.3.1. Control Group
In the control group, at two weeks, small areas of new bone formation were found at
the margins of the defect. Overlying soft tissues were collapsed into the defect. Inflamma-
tory cells were observed.
At eight weeks, new bone formation could be observed near the center of the defect.
These findings were similar to the sham control group shown in previous studies using the
same experimental model [2].
3.3.2. PCL Group
At two weeks, new bone formation could be observed from the margins of the defect.
No inflammatory cells could be observed beneath the membrane. Only a few inflammatory
cells were found above the membrane. No collapse of the PCL/β-TCP membrane was
seen, and the defect space was well-maintained.
At eight weeks, the PCL/β-TCP membrane still maintained its shape and thickness.
The membrane showed good integration with the surrounding tissues. Some parts of
the membrane were resorbed and replaced by connective tissues and new bone. No
inflammatory cells were observed. Compared to week 2, more mature lamellar bone could
be observed. The structural stability of the PCL/β-TCP membrane was comparable to
a previous study in dogs, in which the membrane retained its original shape after eight
weeks [17].
3.3.3. PCL-BG Group
At two weeks, new bone formation could be seen originating from the margins of the
defect and around the graft particles. The defect space was well maintained by the graft
particles and PCL/β-TCP membrane.
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At eight weeks, mature new bone formation could be observed across the entire defect,
and no inflammatory cells were observed. The PCL/β-TCP membrane remained intact
and was integrated with the surrounding tissues (Figure 4). Similar observations were
made with regard to the structural integrity and biocompatibility in a previous study in
dogs at eight weeks [17].
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Figure 4. High magnification view showing slight degradation of the membrane after eight weeks.
PCL/β-TCP membrane exhibiting a porous appearance with the integration of connective tissue and
early new bone (Masson trichrome staining).
3.4. Histomorphometric Analysis
The results from the histomorphometric analysis are presented in Table 2. At two
we ks, the - sho ed significantly greater T A than the control grou
(p = 0.016). At eight weeks, the PCL-BG group exhibited greater TAA than the control and
PCL grou s (p = 0 008). B tween two and eight weeks, among the PCL group, NBA was
greater at eight weeks compared to two weeks (p = 0.043). In addition, among the PCL-BG
group, NBA w s greater at eight weeks compared to two weeks (p = 0.043).
Table 2. Results from the histomorphometric analysis.




CONTROL 4.89 ± 2.51 0.69 ± 0.27
PCL 8.12 ± 4.26 1.01 ± 0.67
PCL-BG 13.09 ± 3.89 * 0.90 ± 0.22
8 weeks
CONTROL 5.02 ± 2.69 0.99 ± 0.64
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4. Discussion
In this study, we evaluated a PCL/β-TCP barrier membrane fabricated using a 3D
printer for GBR of critical sized defects in rabbit calvaria [20]. The main findings were:
(i) the augmented volume was maximized when the membrane was used with bone graft;
(ii) it was possible to gain augmented volume over eight weeks by applying the membrane
alone; and (iii) the PCL/β-TCP membrane was highly biocompatible and demonstrated
good tissue integration.
Space maintenance is possibly one of the most important requirements of GBR [21].
In dentistry, GBR is performed to increase the volume of alveolar ridge for the placement
of dental implants [22]. In order to achieve this, the grafted volume must be maintained
over the healing period required for the newly formed bone to fill the space and eventually
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replace the graft material [23]. In this study, the PCL/β-TCP membrane combined with
synthetic bone graft was able to provide the greatest augmented volume, which was
maintained over eight weeks. This result was supported by the histological data, in which
optimal bone regeneration could be observed inside the defect. The reason for no significant
increase in the volume of new bone might be the grafted particles occupying the defect
space even after eight weeks. It has been shown that grafted particles take up to six months
to become fully replaced by bone [24], and the presence of graft particles may be beneficial
as they help to prevent shrinkage of the graft volume [23,25].
As the PCL/β-TCP membrane in this study exhibited slow degradation rate and good
structural stability, a faster resorbing bone substitute with greater osteoinductivity could
be used together to produce a better quality of new bone. The synthetic bone substitute
in this study comprised a combination of HA and β-TCP at the ratio of 60:40 in weight,
respectively. HA is known to be osteoconductive while β-TCP is not only osteoconductive
but also osteoinductive [26]. Increasing the ratio of the β-TCP component may increase the
rate of new bone formation, but results in faster absorption of the material and decreased
total augmented volume. However, the current membrane with superior structural stability
could accommodate the use of a bone substitute containing higher β-TCP content, thereby
obtaining good quality as well as quantity of regenerated bone.
In this study, it was evident that the PCL/β-TCP membrane can maintain space with-
out the bone graft, as application of the membrane alone resulted in significant increase
of new bone over eight weeks. It could be seen in the histological view that the mem-
brane was able to maintain its original structure without collapsing into the defect space.
Traditionally, GBR was performed with non-resorbable membranes as they can maintain
the barrier function for a controlled period of time, which can be advantageous for the
regeneration of uncontained defects and severely atrophic ridges [1,12]. However, there
was a need for a second surgery for membrane removal and risk of complication involving
frequent membrane exposure [27,28]. The current PCL/β-TCP membrane exhibited slow
degradation rate and sufficient structural stability to provide barrier function for eight
weeks. PCL has been shown to have a degradation rate that is slower than the rate of bone
regeneration [29]. Furthermore, it was shown to have strong mechanical properties that
were maintained even after soaking of the membrane, which can be beneficial for space
maintenance and manual handling during surgery [14]. One possible drawback of the
PCL/β-TCP membrane might be that it has lower wettability compared to the collagen
membrane. Therefore, fixation of the membrane may be necessary for stable positioning
onto the grafted site. Further study needs to be performed over a longer healing period to
assess the degradation characteristics of the current membrane.
Biocompatibility and tissue integration are important properties of a barrier mem-
brane [30]. These are the main advantages of the collagen membrane over non-resorbable
membranes that promote good healing and prevent complications such as membrane expo-
sure [31,32]. In this study, no wound dehiscence or membrane exposure was found during
the clinical observation period. The histological view showed only a few inflammatory
cells at two weeks and good tissue integration of the membrane as shown by connective
tissue growth and intramembranous ossification. These appearances were comparable to
the tissue integration of the collagen membrane in previous studies in the rabbit calvaria [2].
In vitro experiments in the literature have shown that the PCL/β-TCP membrane exhibits
comparable cytocompatibility and osteogenic differentiation as the collagen membrane.
Taken together, the current PCL/β-TCP membrane could be used as an alternative to
collagen membranes in situations where greater duration of action and structural rigidity
is required.
3D printing of the PCL/β-TCP membrane is a rapid and economical solution that
allows diverse variations in shape, porosity, and composition. Design and adaptation
of the membrane to specific defect morphology would help to reduce surgical time and
complication. This technology could be applied to manufacturing a scaffold that may be
used as a vessel for growth factors such as rhBMP-2 in tissue engineering [25,33].
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3D printing can be used to adjust the porosity and pore size of the membrane, which
are associated with the degree of new bone formation and angiogenesis. It has been shown
that 30% porosity and 130 µm pore size were the most optimal for new bone formation [13].
Although the PCL/β-TCP membrane in the current study performed well with the pore
size of 270 µm, further study is needed to assess the effect of varying pore sizes.
Variation in the composition of the biomaterial results in the alteration of chemical and
mechanical properties of the membrane. The addition of β-TCP per se to PCL improved the
biocompatibility and bone formation in vivo [17,34]. Increasing the β-TCP concentration
in vitro has been shown to increase the rate of absorption and hydrophilicity, which were
associated with greater osteogenic cell viability [34,35]. The current study incorporated a
4:1 ratio of PCL:β-TCP. Further research on the degradation characteristics according to
varying concentrations would be useful for achieving the optimal membrane for GBR.
5. Conclusions
In summary, the PCL/β-TCP membrane exhibited good structural stability, biocom-
patibility, and slow degradation. In addition, the greatest augmented volume was produced
when the membrane was used with a bone substitute. Future studies should test differ-
ent bone substitutes complementary to this membrane to find the optimal graft material
for producing the best quality of new bone. Since the membrane in the current study
remained unresorbed over the study period, a further study with longer healing period
should be performed to fully understand its degradation characteristics. Overall, the
3D-printed PCL/β-TCP membrane is a promising biomaterial that could be utilized for
the reconstruction of critical sized defects.
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